QSPR modelling for investigation of different properties of aminoglycoside-derived polymers using 2D descriptors

References

• W.F. Anderson, Gene therapy for genetic diseases, Hum. Gene Ther. 5 (1994), pp. 281–282. doi:10.1089/hum.1994.5.3-281.
   PubMed Web of Science ®Google Scholar
• M.G. Kaplitt, A. Feigin, C. Tang, H.L. Fitzsimons, P. Mattis, P.A. Lawlor, R.J. Bland, D. Young, K. Strybing, D. Eidelberg, and M.J. During, Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson’s disease: An open label, phase I trial, Lancet 369 (2007), pp. 2097–2105. doi:10.1016/S0140-6736(07)60982-9.
   PubMed Web of Science ®Google Scholar
• B.A. Bunnell and R.A. Morgan, Gene therapy for infectious diseases, Clin. Microbiol. Rev. 11 (1998), pp. 42–56. doi:10.1128/CMR.11.1.42.
   PubMed Web of Science ®Google Scholar
• R. Wolkowicz and G. Nolan, Gene therapy progress and prospects: Novel gene therapy approaches for AIDS, Gene Ther. 12 (2005), pp. 467–476. doi:10.1038/sj.gt.3302488.
   PubMed Web of Science ®Google Scholar
• N.A. Horn, J.A. Meek, G. Budahazi, and M. Marquet, Cancer gene therapy using plasmid DNA: Purification of DNA for human clinical trials, Hum. Gene Ther. 6 (1995), pp. 565–573. doi:10.1089/hum.1995.6.5-565.
   PubMed Web of Science ®Google Scholar
• Z.R. Yang, H.F. Wang, J. Zhao, Y.Y. Peng, J. Wang, B.A. Guinn, and L.Q. Huang, Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy, Cancer Gene Ther. 14 (2007), pp. 599–615. doi:10.1038/sj.cgt.7701054.
   PubMed Web of Science ®Google Scholar
• G. Ermak, Emerging Medical Technologies, World scientific publishing Co. Pvt.Ltd, Singapore, 2015.
   Google Scholar
• H. Yin, R.L. Kanasty, A.A. Eltoukhy, A.J. Vegas, J.R. Dorkin, and D.G. Anderson, Non-viral vectors for gene-based therapy, Nat. Rev. Genet. 15 (2014), pp. 541–555. doi:10.1038/nrg3763.
   PubMed Web of Science ®Google Scholar
• C.E. Thomas, A. Ehrhardt, and M.A. Kay, Progress and problems with the use of viral vectors for gene therapy, Nat. Rev. Genet. 4 (2003), pp. 346–358. doi:10.1038/nrg1066.
   PubMed Web of Science ®Google Scholar
• N. Bessis, F.J. GarciaCozar, and M.C. Boissier, Immune responses to gene therapy vectors: Influence on vector function and effector mechanisms, Gene Ther. 11 (2004), pp. S10–S17. doi:10.1038/sj.gt.3302364.
   PubMed Web of Science ®Google Scholar
• C. Baum, O. Kustikova, U. Modlich, Z. Li, and B. Fehse, Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors, Hum. Gene Ther. 17 (2006), pp. 253–263. doi: 10.1089/hum.2006.17.253..
   Google Scholar
• D. Niculescu-Duvaz, J. Heyes, and C.J. Springer, Structure-activity relationship in cationic lipid mediated gene transfection, Curr. Med. Chem. 10 (2005), pp. 1233–1261. doi:10.2174/0929867033457476.
   Web of Science ®Google Scholar
• S.K. Samal, M. Dash, S. Van Vlierberghe, D.L. Kaplan, E. Chiellini, C. Van Blitterswijk, L. Moroni, and P. Dubruel, Cationic polymers and their therapeutic potential, Chem. Soc. Rev. 41 (2012), pp. 7147–7194.
   PubMed Web of Science ®Google Scholar
• D. Pezzoli, F. Olimpieri, C. Malloggi, S. Bertini, A. Volonterio, and G. Candiani, Chitosan-graft-branched polyethylenimine copolymers: Influence of degree of grafting on transfection behavior, PLoS One 7 (2012), pp. e34711. doi:10.1371/journal.pone.0034711.
   PubMed Web of Science ®Google Scholar
• R. Labas, F. Beilvert, B. Barteau, S. David, R. Chèvre, and B. Pitard, Nature as a source of inspiration for cationic lipid synthesis, Genetica 138 (2010), pp. 153–168. doi:10.1007/s10709-009-9405-8.
   PubMed Web of Science ®Google Scholar
• A.D. Miller, The problem with cationic liposome/micelle-based non-viral vector systems for gene therapy, Curr. Med. Chem. 10 (2005), pp. 1195–1211. doi:10.2174/0929867033457485.
   Web of Science ®Google Scholar
• H. Gonzalez, S.J. Hwang, and M.E. Davis, New class of polymers for the delivery of macromolecular therapeutics, Bioconjug. Chem. 10 (1999), pp. 1068–1074. doi:10.1021/bc990072j.
   PubMed Web of Science ®Google Scholar
• J.H. Jeong, S.W. Kim, and T.G. Park, Molecular design of functional polymers for gene therapy, Prog. Polym. Sci. 32 (2007), pp. 1239–1274.
   Web of Science ®Google Scholar
• T. Potta, Z. Zhen, T.S.P. Grandhi, and M.D. Christensen, Discovery of antibiotics-derived polymers for gene delivery using combinatorial synthesis and cheminformatics modeling, Biomaterials 35 (2014), pp. 1977–1988. doi:10.1016/j.biomaterials.2013.10.069.
   PubMed Web of Science ®Google Scholar
• B. Shi, M. Zheng, W. Tao, R. Chung, D. Jin, D. Ghaffari, and O.C. Farokhzad, Challenges in DNA delivery and recent advances in multifunctional polymeric DNA delivery systems, Biomacromolecules 18 (2017), pp. 2231–2246. doi:10.1021/acs.biomac.7b00803.
   PubMed Web of Science ®Google Scholar
• W. Wagner, S. Sakiyama-Elbert, and G. Zhang, Biomaterials Science: An Introduction to Materials in Medicine, Academic Press, London, 2020.
   Google Scholar
• Z. Zhen, T. Potta, M.D. Christensen, E. Narayanan, K. Kanagal, C.M. Breneman, and K. Rege, Accelerated materials discovery using chemical informatics investigation of polymer physicochemical properties and transgene expression efficacy, ACS Biomater. Sci. Eng. 5 (2019), pp. 654–669. doi:10.1021/acsbiomaterials.8b00963.
   PubMed Web of Science ®Google Scholar
• M. Chen, M. Hu, D. Wang, G. Wang, X. Zhu, D. Yan, and J. Sun, Multifunctional hyperbranched glycoconjugated polymers based on natural aminoglycosides, Bioconjug. Chem. 23 (2012), pp. 1189–1199. doi:10.1021/bc300016b.
   PubMed Web of Science ®Google Scholar
• N.D. Stebbins, M.A. Ouimet, and K.E. Uhrich, Antibiotic-containing polymers for localized, sustained drug delivery, Adv. Drug Deliv. Rev. 78 (2014), pp. 77–87. doi:10.1016/j.addr.2014.04.006.
   PubMed Web of Science ®Google Scholar
• K. Rege, A. Ladiwala, S. Hu, M. Breneman, J.S. Dordick, and S.M. Cramer, Investigation of DNA-binding properties of an aminoglycoside-polyamine library using Quantitative Structure-Activity Relationship (QSAR) models, J. Chem. Inf. Model. 45 (2005), pp. 1854–1863. doi:10.1021/ci050082g.
   PubMed Web of Science ®Google Scholar
• B. Miryala, Z. Zhen, T. Potta, C.M. Breneman, and K. Rege, Parallel synthesis and quantitative structure-activity relationship (QSAR) modeling of aminoglycoside-derived lipopolymers for transgene expression, ACS Biomater. Sci. Eng. 1 (2015), pp. 656–668. doi:10.1021/acsbiomaterials.5b00045.
   PubMed Web of Science ®Google Scholar
• K. Roy, S. Kar, and R. Das, Understanding the Basics of QSAR for Applications in Pharmaceutical Sciences and Risk Assessment, Academic press, New York, 2015.
   Google Scholar
• S. Paz-Abuin, M.P. Pellin, M. Paz-Pazos, and A. Lopez-Quintela, Influence of the reactivity of amine hydrogens and the evaporation of monomers on the cure kinetics of epoxy-amine: Kinetic questions, Polymer (Guildf) 38 (1997), pp. 3795–3804. doi:10.1016/S0032-3861(96)00957-3.
   Web of Science ®Google Scholar
• C.W. Yap, PaDEL-descriptor: An open source software to calculate molecular descriptors and fingerprints, J. Comput. Chem. 32 (2011), pp. 1466–1474. doi:10.1002/jcc.21707.
   PubMed Web of Science ®Google Scholar
• AlvaDesc (software for molecular descriptors calculation) version 2.0.2, 2020, https://www.alvascience.com, 2020.
   Google Scholar
• R.W. Kennard and L.A. Stone, Computer aided design of experiments, Technometrics 11 (1969), pp. 137–148. doi:10.1080/00401706.1969.10490666.
   Web of Science ®Google Scholar
• H. Golmohammadi, Z. Dashtbozorgi, and W.E. Acree Jr, Quantitative structure–activity relationship prediction of blood-to-brain partitioning behavior using support vector machine, Eur. J. Pharm. Sci. 47 (2011), pp. 421–429. doi:10.1016/j.ejps.2012.06.021.
   Web of Science ®Google Scholar
• K. Roy, S. Kar, and R.N. Das, A Primer on QSAR/QSPR Modeling: Fundamental Concepts, Springer, New York, 2015.
   Google Scholar
• P.M. Khan and K. Roy, Current approaches for choosing feature selection and learning algorithms in quantitative structure–activity relationships (QSAR), Expert Opin. Drug Discov. 13 (2018), pp. 1075–1089. doi:10.1080/17460441.2018.1542428.
   PubMed Web of Science ®Google Scholar
• S. Wold, M. Sjöström, and L. Eriksson, PLS-regression: A basic tool of chemometrics, Chemom. Intell. Lab. Syst. 58 (2001), pp. 109–130. doi:10.1016/S0169-7439(01)00155-1.
   Web of Science ®Google Scholar
• K. Roy and I. Mitra, On various metrics used for validation of predictive QSAR models with applications in virtual screening and focused library design, Comb. Chem. High Throughput Screen. 14 (2011), pp. 450–474. doi:10.2174/138620711795767893.
   PubMed Web of Science ®Google Scholar
• K. Roy, I. Mitra, P. Ojha, S. Kar, R.N. Das, and H. Kabir, Introduction of rm2 (rank) metric incorporating rank-order predictions as an additional tool for validation of QSAR/QSPR models, Chemom. Intell. Lab. Syst. 118 (2012), pp. 200–210. doi:10.1016/j.chemolab.2012.06.004.
   Web of Science ®Google Scholar
• K. Roy, R.N. Das, P. Ambure, and R.B. Aher, Be aware of error measures. Further studies on validation of predictive QSAR models, Chemom. Intell. Lab. Syst. 152 (2016), pp. 18–33. doi:10.1016/j.chemolab.2016.01.008.
   Web of Science ®Google Scholar
• K. Roy, P. Ambure, S. Kar, and P. Kumar Ojha, Is it possible to improve the quality of predictions from an “intelligent” use of multiple QSAR/QSPR/QSTR models? J. Chemom. 32 (2018), pp. e2992. doi:10.1002/cem.2992.
   Web of Science ®Google Scholar
• L.H. Hall and L.B. Kier, Electrotopological state indices for atom types: A novel combination of electronic, topological, and valence state information, J. Chem. Inf. Comput. Sci. 35 (1995), pp. 1039–1045. doi:10.1021/ci00028a014.
   Google Scholar
• J. Votano, M. Parham, L. Hall, L. Kier, S. Oloff, A. Tropsha, Q. Xie, and W. Tong, Three new consensus QSAR models for the prediction of Ames genotoxicity, Mutagenesis 19 (2004), pp. 365–377. doi:10.1093/mutage/geh043.
   PubMed Web of Science ®Google Scholar
• S. Gupta, N. Basant, D. Mohan, and K.P. Singh, Inter-moieties reactivity correlations: An approach to estimate the reactivity endpoints of major atmospheric reactants towards organic chemicals, RSC Adv. 6 (2016), pp. 50297–50305. doi:10.1039/C6RA06805G.
   Web of Science ®Google Scholar
• R. Todeschini and V. Consonni, Handbook of Molecular Descriptors, Vol. 11, John Wiley & Sons, New Jersey, 2008.
   Google Scholar
• Y.S. Prabhakar, R.K. Rawal, M.K. Gupta, V.R. Solomon, and S.B. Katti, Topological descriptors in modeling the HIV inhibitory activity of 2-aryl-3-pyridyl-thiazolidin-4-ones, Comb. Chem. High Throughput Screen. 8 (2005), pp. 431–437. doi:10.2174/1386207054546531.
   PubMed Web of Science ®Google Scholar
• Z. Wu, D. Li, J. Meng, and H. Wang, Introduction to SIMCA-P and its application, in Handbook of Partial Least Squares, V.V. Esposito, W.W. Chin, J. Henseler, and H. Wang (Eds.), Berlin-Heidelberg, Springer, 2010, pp. 757–774.
   Google Scholar
• K. Roy, Quantitative Structure-Activity Relationships in Drug Design, Predictive Toxicology, and Risk Assessment, IGI Global, Hershey, Pennsylvania, 2015.
   Google Scholar
• K. Roy and G. Ghosh, Introduction of extended topochemical atom (eta)indices in the valence electron mobile (vem) environment as tools for QSAR/QSPR studies, Internet Electron. J. Mol. Des. 2 (2003), pp. 599–620.
   Google Scholar
• A. Karmakar, P. Ambure, T. Mallick, S. Das, K. Roy, and N.A. Begum, Exploration of synthetic antioxidant flavonoid analogs as acetylcholinesterase inhibitors: An approach towards finding their quantitative structure–activity relationship, Med. Chem. Res. 28 (2019), pp. 723–741. doi:10.1007/s00044-019-02330-8.
   Web of Science ®Google Scholar